作者: Rico D. Bense , Christos Sotiriou , Martine J. Piccart-Gebhart , John B. A. G. Haanen , Marcel A. T. M. van Vugt
DOI: 10.1093/JNCI/DJW192
关键词: Internal medicine 、 Survival rate 、 Immunology 、 Trastuzumab 、 Adjuvant therapy 、 Oncology 、 Breast cancer 、 Estrogen receptor 、 Hazard ratio 、 Immunotherapy 、 Neoadjuvant therapy 、 Medicine
摘要: … toward either the M1 or M2 macrophage subtypes. The hypothesis that M0 macrophage fraction seems relevant in both OS and DFS underlines its possible impact on intrinsic ER-…